Earnings calendar/ALNY
Alnylam Pharmaceuticals, Inc. (ALNY)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Oct 29, 2026
Consensus estimate row
EPS target
$1.78
Street estimate
Revenue target
$1.44B
Street estimate
Trailing EPS (avg 4Q)
$1.34
Beat rate last 4: 50%
Latest EPS YoY
+337.3%
vs 2025-07-31
Latest revenue YoY
+66.9%
How results look so far
Trailing revenue (avg 4Q)
$1.20B
Printed quarters
EPS beat rate (4Q)
50%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 30, 2026
EPS miss
EPS actual / est
$1.21 / $1.63
-25.8%
Revenue actual / est
$1.29B / $1.32B
-2.4%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 10/29/2026upcoming | $1.78 | Pending | — | $1.44B | Pending | — |
| 7/30/2026 | $1.63 | $1.21 | -25.8% | $1.32B | $1.29B | -2.4% |
| 5/7/2026upcoming | $1.50 | Pending | — | $1.13B | Pending | — |
| 4/30/2026 | $0.87 | $1.51 | +73.2% | $1.12B | $1.17B | +4.6% |
| 2/12/2026 | $1.16 | $0.82 | -29.3% | $1.15B | $1.10B | -4.5% |
| 10/30/2025 | $0.56 | $1.84 | +228.0% | $959.4M | $1.25B | +30.2% |
| 7/31/2025 | $-0.54 | $-0.51 | +6.2% | $662.9M | $773.7M | +16.7% |
| 5/1/2025 | $-0.89 | $-0.44 | +50.6% | $585.1M | $594.2M | +1.5% |
| 2/13/2025 | $-0.62 | $-0.65 | -4.8% | $582.6M | $593.2M | +1.8% |
| 10/31/2024 | $-0.92 | $-0.87 | +5.1% | $532.9M | $500.9M | -6.0% |
| 8/1/2024 | $-1.07 | $-0.13 | +87.9% | $447.2M | $659.8M | +47.5% |
| 5/2/2024 | $-1.12 | $-0.52 | +53.6% | $428.0M | $494.3M | +15.5% |
| 2/15/2024 | $-1.20 | $-1.10 | +8.3% | $436.9M | $439.7M | +0.6% |
| 11/2/2023 | $-1.34 | $1.15 | +185.8% | $396.8M | $750.5M | +89.2% |
| 8/3/2023 | $-1.37 | $-2.21 | -61.3% | $332.3M | $318.8M | -4.1% |
| 5/4/2023 | $-1.77 | $-1.40 | +20.9% | $312.3M | $319.3M | +2.2% |
| 2/23/2023 | $-1.90 | $-1.68 | +11.6% | $313.1M | $335.0M | +7.0% |
| 10/27/2022 | $-1.77 | $-3.32 | -87.6% | $291.7M | $264.3M | -9.4% |
| 7/28/2022 | $-1.63 | $-2.29 | -40.5% | $255.6M | $224.8M | -12.0% |
| 4/28/2022 | $-1.84 | $-2.00 | -8.7% | $240.9M | $213.3M | -11.5% |